C11 H15 N2 O9 P
350.219
DT
[(1S,3R,4S,7R)-7-HYDROXY-3-(THYMIN-1-YL)-2,5-DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE
T
N
0
N
2002-02-06
1GV6
N
2011-06-04
EBI
REL
ATOMN
ATL
RNA linking
O1P
0
6.896
-11.308
-15.933
1
N
OP1
ATL
N
0.268
0.986
-4.881
1
N
O
P
0
5.436
-11.135
-15.771
1
N
P
ATL
N
0.952
-0.123
-4.181
2
N
P
O2P
0
4.587
-12.315
-15.490
1
N
OP2
ATL
N
2.535
-0.041
-4.465
3
N
O
O5*
0
5.179
-10.046
-14.608
1
N
O5'
ATL
N
0.684
-0.005
-2.598
4
N
O
C5*
0
6.050
-8.948
-14.391
1
N
C5'
ATL
N
-0.729
-0.084
-2.411
5
N
C
C4*
0
5.274
-7.834
-13.682
1
N
C4'
ATL
N
-1.054
0.022
-0.920
6
S
C
O4*
0
4.358
-7.216
-14.579
1
N
O4'
ATL
N
-0.498
-1.015
-0.063
7
N
O
C3*
0
6.074
-6.647
-13.163
1
N
C3'
ATL
N
-2.570
-0.019
-0.505
8
R
C
O3*
0
6.993
-6.935
-12.122
1
N
O3'
ATL
N
-3.321
1.058
-1.066
9
N
O
C2*
0
4.772
-6.031
-12.660
1
N
C2'
ATL
N
-2.250
0.196
1.019
10
S
C
O2*
0
4.200
-7.017
-11.806
1
N
O2'
ATL
N
-1.465
1.423
0.969
11
N
O
C1*
0
3.988
-5.982
-13.979
1
N
C1'
ATL
N
-1.178
-0.923
1.204
12
R
C
C6*
0
4.521
-8.262
-12.411
1
N
C6'
ATL
N
-0.642
1.350
-0.212
13
N
C
N1
0
2.514
-5.831
-13.803
1
N
N1
ATL
N
-0.233
-0.551
2.260
14
N
N
C2
0
1.995
-4.545
-13.623
1
N
C2
ATL
N
-0.597
-0.666
3.550
15
N
C
O2
0
2.697
-3.541
-13.519
1
N
O2
ATL
N
-1.707
-1.079
3.826
16
N
O
N3
0
0.611
-4.443
-13.573
1
N
N3
ATL
N
0.250
-0.332
4.541
17
N
N
C4
0
-0.296
-5.489
-13.689
1
N
C4
ATL
N
1.486
0.121
4.253
18
N
C
O4
0
-1.503
-5.258
-13.617
1
N
O4
ATL
N
2.254
0.424
5.148
19
N
O
C5
0
0.324
-6.794
-13.891
1
N
C5
ATL
N
1.880
0.253
2.899
20
N
C
C5M
0
-0.520
-8.039
-14.098
1
N
C5M
ATL
N
3.254
0.763
2.550
21
N
C
C6
0
1.674
-6.918
-13.919
1
N
C6
ATL
N
1.010
-0.089
1.926
22
N
C
OXT
0
4.870
-10.407
-17.107
1
N
OXT
ATL
Y
0.383
-1.529
-4.718
23
N
O
HO2P
0
3.649
-12.203
-15.386
0
N
HO2P
ATL
N
2.652
-0.115
-5.422
24
N
H
1H5*
0
6.893
-9.269
-13.776
1
N
H5'
ATL
N
-1.213
0.732
-2.948
25
N
H
2H5*
0
6.423
-8.567
-15.343
0
N
H5''
ATL
N
-1.094
-1.036
-2.796
26
N
H
H3*
0
6.533
-6.082
-13.978
1
N
H3'
ATL
N
-3.031
-0.987
-0.703
27
N
H
HA
0
7.492
-6.194
-11.798
1
N
HA
ATL
N
-4.159
1.095
-0.584
28
N
H
1H2*
0
4.884
-5.057
-12.186
1
N
H2'
ATL
N
-3.098
0.192
1.703
29
N
H
H1*
0
4.366
-5.172
-14.603
1
N
H1'
ATL
N
-1.659
-1.870
1.445
30
N
H
1H9*
0
3.625
-8.832
-12.655
0
N
H9'1
ATL
N
0.411
1.321
0.062
31
N
H
2H9*
0
5.175
-8.838
-11.755
0
N
H9'2
ATL
N
-0.840
2.202
-0.863
32
N
H
H3
0
0.225
-3.521
-13.427
1
N
H3
ATL
N
-0.027
-0.422
5.466
33
N
H
1H5M
0
-1.369
-7.810
-14.740
1
N
H71
ATL
N
3.803
0.984
3.465
34
N
H
2H5M
0
0.071
-8.820
-14.583
1
N
H72
ATL
N
3.790
0.004
1.980
35
N
H
3H5M
0
-0.872
-8.408
-13.136
1
N
H73
ATL
N
3.164
1.670
1.952
36
N
H
H6
0
2.095
-7.899
-14.059
1
N
H6
ATL
N
1.294
0.000
0.888
37
N
H
HXT
0
3.932
-10.295
-17.003
1
N
HXT
ATL
N
0.854
-2.224
-4.238
38
N
H
N
1
N
doub
N
2
N
sing
N
3
N
sing
N
4
N
sing
N
5
N
sing
N
6
N
sing
N
7
N
sing
N
8
N
sing
N
9
N
sing
N
10
N
sing
N
11
N
sing
N
12
N
sing
N
13
N
sing
N
14
N
sing
N
15
N
sing
N
16
N
sing
N
17
N
sing
N
18
N
sing
N
19
N
sing
N
20
N
sing
N
21
N
sing
N
22
N
sing
N
23
N
sing
N
24
N
sing
N
25
N
sing
N
26
N
sing
N
27
N
sing
N
28
N
doub
N
29
N
sing
N
30
N
sing
N
31
N
sing
N
32
N
doub
N
33
N
sing
N
34
N
sing
N
35
N
doub
N
36
N
sing
N
37
N
sing
N
38
N
sing
N
39
N
sing
N
40
N
sing
EBI
RCSB
RCSB
O=C1C(=CN(C(=O)N1)C3OC2(C(O)C3OC2)COP(=O)(O)O)C
CC1=CN([C@@H]2O[C@@]3(CO[C@H]2[C@H]3O)CO[P](O)(O)=O)C(=O)NC1=O
CC1=CN([CH]2O[C]3(CO[CH]2[CH]3O)CO[P](O)(O)=O)C(=O)NC1=O
CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]3[C@H]([C@](O2)(CO3)COP(=O)(O)O)O
CC1=CN(C(=O)NC1=O)C2C3C(C(O2)(CO3)COP(=O)(O)O)O
InChI=1S/C11H15N2O9P/c1-5-2-13(10(16)12-8(5)15)9-6-7(14)11(22-9,3-20-6)4-21-23(17,18)19/h2,6-7,9,14H,3-4H2,1H3,(H,12,15,16)(H2,17,18,19)/t6-,7+,9+,11-/m0/s1
BXKGBLDLIZEIJX-QJSROADHSA-N
1-{2,5-anhydro-4-[(phosphonooxy)methyl]-beta-D-lyxofuranosyl}-5-methylpyrimidine-2,4(1H,3H)-dione
[(1S,4S,5R,7R)-7-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)-3,6-dioxabicyclo[2.2.1]heptan-1-yl]methyl dihydrogen phosphate